Baxter’s New Vivia Home HD Machine is (Almost) Here!
Baxter presented human studies data at the ERA-EDTA Congress in Amsterdam this June supporting the safety and efficacy of the new Vivia home dialysis system. With four treatments per week for 10 weeks, averaging 3.8 hours per treatment, the mean weekly Kt/V of the 22 US patients was 2.97, with no serious adverse events related to the machine. A small nocturnal trial was also done in Canada.
Read the full article » | Posted 07-03-2014
Related Articles
- Global Wearable Artificial Kidney Market Expected to Grow Posted 07-12-2024
- Byonyks X1: a New, Small, Portable APD Machine Posted 06-14-2024
- The Public-Private ASN, DHSS, KidneyX Partnership is 5 Years Old This Year Posted 05-09-2024
- New Measure of Home Dialysis Dropout Posted 01-16-2024